CN110447634A - A kind of monkey red blood cells save liquid and application - Google Patents

A kind of monkey red blood cells save liquid and application Download PDF

Info

Publication number
CN110447634A
CN110447634A CN201910568840.0A CN201910568840A CN110447634A CN 110447634 A CN110447634 A CN 110447634A CN 201910568840 A CN201910568840 A CN 201910568840A CN 110447634 A CN110447634 A CN 110447634A
Authority
CN
China
Prior art keywords
red blood
monkey
blood cells
liquid
monkey red
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910568840.0A
Other languages
Chinese (zh)
Inventor
冯燕
徐昌平
卢亦愚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Center for Disease Control and Prevention
Original Assignee
Zhejiang Center for Disease Control and Prevention
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Center for Disease Control and Prevention filed Critical Zhejiang Center for Disease Control and Prevention
Priority to CN201910568840.0A priority Critical patent/CN110447634A/en
Publication of CN110447634A publication Critical patent/CN110447634A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients

Abstract

The invention discloses a kind of monkey red blood cells to save liquid and its application.The monkey red blood cells save liquid and are able to maintain the integrality of monkey red blood cells, and can be avoided the growth of the microorganisms such as bacterium.Preservation system includes glucose, Tris-HCL, ATP, mannose, the chief actives reagent such as potassium citrate.Preservation liquid of the invention can enhance the nutrition supply of red blood cell, be protected its cell membrane, and reduce the metabolism etc. of red blood cell, to extend the holding time of red blood cell.The monkey red blood cells of acquisition can be reserved for 6 months, can be applied to the fields such as the serological surveillance of morbilli.

Description

A kind of monkey red blood cells save liquid and application
Technical field
The present invention relates to biology techniques fields more particularly to a kind of monkey red blood cells to save liquid and application thereof.
Background technique
Morbilli may be that the mankind's candidate third eliminated after the polio that exterminates smallpox and will eliminate passes It catches an illness.Generally use measurement serum Measles Antibody Level Among both at home and abroad to understand the immune state of crowd, hemagglutination-inhibition test is to survey Determine experimental method common, quickly, easy in measles antibody, but the disadvantage is that the test is not only coagulated with fresh monkey red blood cells Collection inhibit test, also need with a large amount of monkey red blood cells absorb it is to be measured enter serum in nonspecific agglutination substance.However monkey is red thin Born of the same parents source is few, and is not easy to save for a long time, and the extensive development of hemagglutination-inhibition test is made to be very limited.Therefore one kind is researched and developed to match Side, enhances the nutrition supply of red blood cell, is protected its cell membrane, and reduces the metabolism etc. of red blood cell, to extend red The holding time of blood cell.Measles Hemagglutination Inhibition Antibody measurement large-scale promotion is possibly realized by this, promotes the serum school superintendent of morbilli The development with seroepidemiology work is surveyed, is made contributions for control or even the final work for eliminating morbilli.
Summary of the invention
The object of the present invention is to provide a kind of monkey red blood cells to save liquid and application thereof.The monkey red blood cells save liquid and can protect The integrality of monkey red blood cell is held, and can be avoided the growth of the microorganisms such as bacterium.
The technical solution adopted by the present invention:
The present invention provides a kind of monkey red blood cells preservation liquid for extending monkey red blood cells storage life, and the preservation liquid is by as follows The group of proportion is grouped as: glucose 150mmol/L, ammonium chloride
50mmol/L, adenosine triphyosphate (ATP) 3mmol/L, adenine 2mmol/L, mannitol 50mmol/L, lemon Lemon acid potassium 20mmol/L, dipotassium hydrogen phosphate 25mmol/L, potassium dihydrogen phosphate 20mmol/L, solvent is distilled water, uses sodium hydroxide It is 7.1 that aqueous solution, which adjusts pH value,.
Save liquid the present invention also provides a kind of monkey red blood cell and saving the application in monkey red blood cell, the application be by Monkey red blood cell saves liquid with monkey red blood cell and is saved according to volume ratio 1:1 mixing, is able to extend monkey red blood cell in room temperature (25- 30 DEG C) pot-life 6 months.
Compared with prior art, saving liquid the beneficial effects are mainly reflected as follows: monkey red blood cell of the present invention can be Phenomena such as saving monkey red blood cell integrality under room temperature, haemolysis not occurring.It is experimentally confirmed that being saved using preservation liquid of the invention Monkey red blood cells rupture does not occur after 6 months for monkey red blood cell.In addition, without the growth of the microorganisms such as bacterium, inhibit convenient for blood clotting etc. The operation of test.
Detailed description of the invention
The preservation effect figure of the fresh acquisition monkey red blood cells of Fig. 1, the left side are that addition saves liquid, and the right is not add preservation liquid.
Fig. 2 saves the effect picture of 1 month monkey red blood cells, and the left side is that addition saves liquid, and the right is not add preservation liquid.
Fig. 3 saves the effect picture of 2 months monkey red blood cells, and the left side is that addition saves liquid, and the right is not add preservation liquid.
Fig. 4 saves the effect picture of 3 months monkey red blood cells, and the left side is that addition saves liquid, and the right is not add preservation liquid.
Fig. 5 saves the effect picture of 4 months monkey red blood cells, and the left side is that addition saves liquid, and the right is not add preservation liquid.
Fig. 6 saves the effect picture of 5 months monkey red blood cells, and the left side is that addition saves liquid, and the right is not add preservation liquid.
Fig. 7 saves the effect picture of 6 months monkey red blood cells, and the left side is that addition saves liquid, and the right is not add preservation liquid.
Specific embodiment
The present invention is described further combined with specific embodiments below, but protection scope of the present invention is not limited in This:
1 monkey red blood cells of embodiment save liquid
Monkey red blood cells save liquid and are made of the raw material matched as follows: glucose 150mmol/L, ammonium chloride 50mmol/L, gland Purine nucleosides triphosphoric acid (ATP) 3mmol/L, adenine 2mmol/L, mannitol 50mmol/L, potassium citrate 20mmol/L, phosphoric acid Hydrogen dipotassium 25mmol/L, potassium dihydrogen phosphate 20mmol/L, solvent is distilled water, and adjusting pH value with sodium hydrate aqueous solution is 7.1.
2 monkey red blood cells of embodiment save liquid and are saving the application in monkey red blood cells
1, the acquisition of monkey red blood cells
Rhesus macaque is picked up from, 4 DEG C of preservations in vein sterile blood sampling postposition Alsever's Solution use in one week.
2, morbilli hemagglutination-inhibition test
A) reagent: there is measles haemagglutinin 1 in morbilli HI test kit, serum non-specific adsorption substance 1 Bottle (for absorbing the nonspecific agglutination substance in human serum), test monkey red blood cells and the mixing for saving liquid volume ratio 1:1 1 bottle of liquid.Wherein, mixed liquor is the fresh monkey red blood cells of acquisition, and 1:1 is stored in the preservation liquid of embodiment 1 by volume respectively, In It saves 1 month, 2 months, 3 months, 4 months, 5 months and 6 months respectively at room temperature.In addition control group is set, monkey red blood cell is straight It connects and is stored in anti-coagulants.
B) morbilli hemagglutination-inhibition test is carried out to 5 parts of crowd's serum to be measured that laboratory saves, " plan is exempted from referring to the Ministry of Public Health Epidemic disease technical management regulation " it carries out.Morbilli HI test kit application method is located referring to kit specification in serum in advance When reason, draws 60 μ L of serum to be checked and be added in 1ml plastics point bottom tube, 56 DEG C of inactivations, 30 minutes add the blood mixed well Clear 90 μ L of non-specific adsorption substance.After the two is shaked mixing, 4 DEG C are set overnight, next day Aspirate supernatant is 1:2 diluted blood Clearly, following steps are the same as conventional morbilli hemagglutination-inhibition test.Different time (1 month, 2 months, 3 months, 4 months, 5 months and 6 A month) save sensitive monkey red blood cells corkage after, washed 3 times with physiology salt, it is red that hematocrit monkey red blood cells with physiological saline are made into 1% monkey Cell suspension carries out hemagglutination-inhibition test, the results are shown in Table 1.
The monkey red blood cells of the different holding times of table 1 are used for morbilli hemagglutination-inhibition test (Measles Hemagglutination Inhibition Antibody titre)

Claims (3)

1. a kind of monkey red blood cells save liquid, it is characterised in that the preservation liquid is grouped as by the group matched as follows: glucose 150mmol/L, ammonium chloride 50mmol/L, adenosine triphyosphate (ATP) 3mmol/L, adenine 2mmol/L, mannitol 50mmol/L, potassium citrate 20mmol/L, dipotassium hydrogen phosphate 25mmol/L, potassium dihydrogen phosphate 20mmol/L, solvent are distilled water, PH value is 7.1.
2. monkey red blood cell described in a kind of claim 1 saves liquid and is saving the application in monkey red blood cell.
3. application as claimed in claim 2, it is characterised in that the application be monkey red blood cell and monkey red blood cell are saved liquid by It is saved according to volume ratio 1:1 mixing.
CN201910568840.0A 2019-06-27 2019-06-27 A kind of monkey red blood cells save liquid and application Pending CN110447634A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910568840.0A CN110447634A (en) 2019-06-27 2019-06-27 A kind of monkey red blood cells save liquid and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910568840.0A CN110447634A (en) 2019-06-27 2019-06-27 A kind of monkey red blood cells save liquid and application

Publications (1)

Publication Number Publication Date
CN110447634A true CN110447634A (en) 2019-11-15

Family

ID=68481719

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910568840.0A Pending CN110447634A (en) 2019-06-27 2019-06-27 A kind of monkey red blood cells save liquid and application

Country Status (1)

Country Link
CN (1) CN110447634A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110907642A (en) * 2019-12-02 2020-03-24 青岛农业大学 Kit and method for rapidly detecting canine parvovirus antigen and canine parvovirus antibody
CN111713487A (en) * 2020-06-30 2020-09-29 上海市血液中心 Reagent erythrocyte preservation system and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267269A (en) * 1980-02-05 1981-05-12 Baxter Travenol Laboratories, Inc. Red cell storage solution
EP0313808A2 (en) * 1987-09-21 1989-05-03 Stein Holme Synthetic, plasma-free, transfusible storage medium for red blood cells
CN1195965A (en) * 1995-06-05 1998-10-14 加州大学评议会 Method using oxygen removal for extending useful shelf-life of refrigerated red blood cells
CN106110421A (en) * 2016-07-01 2016-11-16 翁炳焕 Rhesus monkey erythrocytes adsorber
CN106561634A (en) * 2016-11-14 2017-04-19 北京乐普医疗科技有限责任公司 Red cell storage solution and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267269A (en) * 1980-02-05 1981-05-12 Baxter Travenol Laboratories, Inc. Red cell storage solution
EP0313808A2 (en) * 1987-09-21 1989-05-03 Stein Holme Synthetic, plasma-free, transfusible storage medium for red blood cells
CN1195965A (en) * 1995-06-05 1998-10-14 加州大学评议会 Method using oxygen removal for extending useful shelf-life of refrigerated red blood cells
CN106110421A (en) * 2016-07-01 2016-11-16 翁炳焕 Rhesus monkey erythrocytes adsorber
CN106561634A (en) * 2016-11-14 2017-04-19 北京乐普医疗科技有限责任公司 Red cell storage solution and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
卢亦愚等: "麻疹血凝抑制试验试剂盒的研制与应用", 《中国计划免疫》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110907642A (en) * 2019-12-02 2020-03-24 青岛农业大学 Kit and method for rapidly detecting canine parvovirus antigen and canine parvovirus antibody
CN111713487A (en) * 2020-06-30 2020-09-29 上海市血液中心 Reagent erythrocyte preservation system and preparation method thereof

Similar Documents

Publication Publication Date Title
Menger et al. Enzyme catalysis in water pools
Dickens Interaction of halogenacetates and SH compounds: The reaction of halogenacetic acids with glutathione and cysteine. The mechanism of iodoacetate poisoning of glyoxalase1
Kuo et al. Cyclic Nucleotide-dependent Protein Kinases: X. AN ASSAY METHOD FOR THE MEASUREMENT OF GUANOSINE 3′, 5′-MONOPHOSPHATE IN VARIOUS BIOLOGICAL MATERIALS AND A STUDY OF AGENTS REGULATING ITS LEVELS IN HEART AND BRAIN
Holland et al. ENTEROVIRAL RIBONUCLEIC ACID: I. Recovery from Virus and Assimilation by Cells
Lindenmayer et al. Incorporation of inorganic phosphate-32 into a Na+, K+-ATPase preparation: stimulation by ouabain
CN110447634A (en) A kind of monkey red blood cells save liquid and application
Jeffrey et al. Activity of an attached and free-living Vibrio sp. as measured by thymidine incorporation, p-iodonitrotetrazolium reduction, and ATP/DNA ratios
Inglis Requirement of arginine for the replication of herpes virus
CN104404127A (en) Blood alanine aminotransferase detecting reagent with high stability
Akcay et al. The real and apparent plasma oxalate
CN106434526A (en) Non-serum non-animal-origin-additive insect cell culture medium
CN107044978B (en) Glutathione electrogenerated chemiluminescence measuring method based on gold nano cluster probe
CN105424930A (en) Method for rapidly detecting staphylococcus aureus
Bartlett et al. Erythrocyte carbohydrate metabolism: II. Chromatographic isolation of monophosphoglycerate, diphosphoglycerate, and adenosine triphosphate and their metabolic turnover with glucose carbon
Asrow Semiautomated enzymic micro methods for blood glucose and lactic acid on a single filtrate
CN107505422B (en) Method for separating and detecting five compounds of adenosine triphosphate, adenosine diphosphate, adenosine monophosphate, adenosine and deoxynucleotide at one time
Kleeman et al. Fate and distribution of Fe59 labelled ferrocyanide in humans and dogs.
Rowe Colloid osmotic pressures of dextran, serum and dextran–serum mixtures
Norris et al. Further studies on Xanthopterin and other pteridines in bone marrow cultures
CN104195221B (en) A kind of compound stabilizer for Glucose estimation kit
CN107607724A (en) A kind of compound stabilizer and its application for Complement C_3 measure kit
Hopwood et al. Sulphamidase activity in leucocytes, cultured skin fibroblasts and amniotic cells: diagnosis of the Sanfilippo A syndrome with the use of a radiolabelled disaccharide substrate
CN103207173A (en) Enzymological detection method
Branda Transport of 5-methyltetrahydrofolic acid in erythrocytes from various mammalian species
CN1595154B (en) Refined citric acid quantitative determination reagent

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20191115